ATRC Symposium

Monday, October 17, 2016 – Mission Bay Conference Center, Owens Street, San Francisco, CA

Recombinant antibodies are ubiquitous regents in research and are essential therapeutics, yet it remains difficult to generate high quality antibodies to many important targets. This symposium, organized by the Antibody Technology Research Center (ATRC) at UCSF, brings together scientists developing technologies to generate recombinant antibodies to medically-relevant and technically-challenging targets. Exciting results on phage library design, use of antibodies for structure determination, and antibodies targeting post-translational modifications will be presented. Attendees will have the opportunity to explore collaborative relationships with the ATRC.


8:00 – 8:30 AM                  Registration, Coffee

                     Poster set up on Mezzanine

8:30- 8:45                          Overview of ATRC

                                          James D. Marks, M.D., Ph.D., Center Director

8:45 – 9:15 AM                   TR&D 1: Renewable Antibodies to Secreted Proteins and Single and Multi-pass Cell Surface Receptors

           James D. Marks, M.D., Ph.D., TR&D1 Project Leader

9:15 – 9:45 AM                   TR&D 2: Antibodies for Characterizing the Structure and Function of Challenging Protein Targets

            Charles Craik, Ph.D., TR&D2 Project Leader

9:45 - 10:15                        TR&D 3:  Industrialized recombinant antibody generation for research and disease

                                          James A. Wells, Ph.D., TR&D3 Project Leader

10:15 – 10:45 AM              Coffee and Poster viewing on Mezzanine

11:00 – 11:30 AM              Library design and construction panel discussion

11:30-12:30 AM                 Antibodies to membrane proteins

                                           Vaughn Smider, M.D., Ph.D. The Scripps Research Institute

12:30 –1:30                        Lunch in Lobby (Posters on Mezzanine available for viewing)

1:00 – 3:00 PM                   Collaborative Projects (DBPs):

                                            John Gross, Ph.D., Yifan Cheng, Ph.D., Mike Evans, Ph.D., Anna Wu, Ph.D. and others TBN

3:00 – 3:20 PM                    Coffee - Mezzanine

3:20 – 4:10 PM                    Development of BiTE antibodies and Blincyto®

Patrick Baeuerle, Ph.D. – MPM Capital and Harpoon Therapeutics Inc.,

4:10 – 4:40 PM                    Joe Gray, Ph.D.  -- Oregon Health Sciences University


4:40 – 5:20 PM                    Panel discussion on Future directions


5:20 – 7:30  PM                   Networking Reception and Poster Viewing -  Wine and Cheese




Registration for the ATRC symposium: